XENON PHARMACEUTICALS INC (XENE) Stock Analyst Earnings Estimates
NASDAQ:XENE - Nasdaq - CA98420N1050 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 32.17M 371.01% | 18.44M -42.68% | 9.43M -48.86% | 2.11M -100.00% | 300.002K | 5.1M 1,599.99% | 42.74M 738.04% | 200.65M 369.47% | 506.58M 152.47% | 841.03M 66.02% | 1.146B 36.26% | 1.386B 20.94% | 1.744B 25.83% | |
| EBITDA YoY % growth | -30.66M 27.67% | -78.08M -154.66% | -127.52M -63.32% | -214.333M -65.08% | -279.344M -32.70% | -324.885M -16.30% | -306.703M 5.60% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -31.3M 26.90% | -78.99M -152.36% | -129.14M -63.49% | -218.198M -65.75% | -280.316M -30.96% | -329.622M -17.59% | -369.401M -12.07% | -279.117M 24.44% | -27.024M 90.32% | 256.83M 1,050.37% | 487.8M 89.93% | 642.77M 31.77% | 917.48M 42.74% | |
| Operating Margin | -97.30% | -428.36% | -1,369.46% | -10,341.13% | -93,437.77% | -6,463.18% | -864.30% | -139.11% | -5.33% | 30.54% | 42.57% | 46.38% | 52.61% | |
| EPS YoY % growth | -0.81 47.40% | -1.77 -118.52% | -2.04 -15.25% | -2.91 -33.33% | -3.17 -16.36% | -3.80 -20.07% | -4.22 -10.92% | -2.63 37.71% | -0.55 79.22% | 2.28 517.94% | 5.11 124.15% | 8.98 75.64% | 14.11 57.10% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.88 -37.17% | -0.88 -41.76% | -0.93 -23.87% | -0.97 -19.84% | -0.94 -6.51% | -0.99 -12.57% | -1.01 -8.69% | -1.04 -7.18% | -1.09 -16.73% |
| Revenue Q2Q % growth | 339.997K | -100.00% | N/A | N/A | N/A | N/A | |||
| EBITDA Q2Q % growth | -76.551M -52.63% | -74.929M -28.21% | -75.827M -11.76% | -76.138M -4.01% | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -77.296M -43.95% | -76.512M -29.59% | -81.692M -18.22% | -85.513M -17.49% | -86.533M -11.95% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.81 -10.96% | -0.83 | 0.02 | 2.60% |
| Q2 2024 Q2Q % growth | -0.75 -4.17% | -0.71 | -0.04 | -5.10% |
| Q1 2024 Q2Q % growth | -0.62 1.59% | -0.68 | 0.06 | 8.49% |
| Q4 2023 Q2Q % growth | -0.64 -12.28% | -0.77 | 0.13 | 17.35% |
| Q3 2023 Q2Q % growth | -0.73 -28.07% | -0.79 | 0.06 | 7.55% |
| Q2 2023 Q2Q % growth | -0.72 -30.91% | -0.71 | -0.01 | -1.23% |
| Q1 2023 Q2Q % growth | -0.63 -80.00% | -0.63 | 0.00 | 0.64% |
| Q4 2022 Q2Q % growth | -0.57 -18.75% | -0.60 | 0.03 | 4.45% |
| Q3 2022 Q2Q % growth | -0.57 -58.33% | -0.53 | -0.04 | -8.16% |
| Q2 2022 Q2Q % growth | -0.55 -7.84% | -0.49 | -0.06 | -11.64% |
| Q1 2022 Q2Q % growth | -0.35 16.67% | -0.41 | 0.06 | 15.39% |
| Q4 2021 Q2Q % growth | -0.48 -41.18% | -0.38 | -0.10 | -26.96% |
| Q3 2021 Q2Q % growth | -0.36 -44.00% | -0.39 | 0.03 | 7.93% |
| Q2 2021 Q2Q % growth | -0.51 | -0.49 | -0.02 | -4.44% |
| Q1 2021 Q2Q % growth | -0.42 -90.91% | -0.44 | 0.02 | 4.79% |
| Q4 2020 Q2Q % growth | -0.34 19.05% | -0.41 | 0.07 | 16.61% |
| Q3 2020 Q2Q % growth | -0.25 24.24% | -0.15 | -0.10 | -61.86% |
| Q2 2020 Q2Q % growth | 0.00 100.00% | -0.24 | 0.24 | 100.00% |
| Q1 2020 Q2Q % growth | -0.22 47.62% | -0.33 | 0.11 | 33.06% |
| Q4 2019 Q2Q % growth | -0.42 | -0.49 | 0.07 | 14.81% |
| Q3 2019 Q2Q % growth | -0.33 | -0.49 | 0.16 | 32.95% |
| Q2 2019 Q2Q % growth | -0.37 | -0.47 | 0.10 | 21.14% |
| Q1 2019 Q2Q % growth | -0.42 | -0.37 | -0.05 | -14.38% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | 1.93M | -1.93M | -100.00% | |
| Q3 2023 Q2Q % growth | -100.00% | 1.479M | -1.479M | -100.00% |
| Q2 2023 Q2Q % growth | -100.00% | 408K | -408K | -100.00% |
| Q1 2023 Q2Q % growth | -100.00% | 582.859K | -582.859K | -100.00% |
| Q4 2022 Q2Q % growth | -100.00% | 2.329M | -2.329M | -100.00% |
| Q3 2022 Q2Q % growth | 130K -98.40% | 3.079M | -2.949M | -95.78% |
| Q2 2022 Q2Q % growth | 540K -75.68% | 3.626M | -3.086M | -85.11% |
| Q1 2022 Q2Q % growth | 8.77M 101.15% | 8.874M | -104K | -1.17% |
| Q4 2021 Q2Q % growth | 3.74M -27.38% | 5.075M | -1.335M | -26.31% |
| Q3 2021 Q2Q % growth | 8.12M 23.97% | 10.43M | -2.31M | -22.15% |
| Q2 2021 Q2Q % growth | 2.22M -83.41% | 2.375M | -155K | -6.53% |
| Q1 2021 Q2Q % growth | 4.36M -38.42% | 3.026M | 1.334M | 44.08% |
| Q4 2020 Q2Q % growth | 5.15M 54.65% | 3.28M | 1.87M | 57.01% |
| Q3 2020 Q2Q % growth | 6.55M 87.14% | 10.257M | -3.707M | -36.14% |
| Q2 2020 Q2Q % growth | 13.38M | 7.037M | 6.343M | 90.14% |
| Q1 2020 Q2Q % growth | 7.08M | 4.59M | 2.49M | 54.25% |
| Q4 2019 Q2Q % growth | 3.33M | 5.1M | -1.77M | -34.71% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | -0.47% | -0.69% |
| Revenue | N/A | N/A | -5.88% | -5.88% |